Tenax Therapeutics (TENX) Competitor Comparison
We are evaluating the key criteria listed to compare Tenax Therapeutics (TENX) against its competitors in the Biotechnology industry.
Market Capitalization
351 / 368Gross Profits
0 / 278Total Revenue
0 / 300EBITDA
48 / 337Free Cashflow
66 / 352Quick Ratio
31 / 357Earnings per Share
352 / 359Dividend yield
0 / 6Total Cash
320 / 358Performance 3 years
368 / 368Performance 5 years
366 / 368Performance 10 years
366 / 368Linearity 3 years
324 / 368Linearity 5 years
196 / 368Linearity 10 years
287 / 368Total Rank
277 / 368Dividend Rank
285 / 368Valuation Rank
268 / 368Piotroski Rank
222 / 368Muliplier Rank
117 / 368Dividend yield - TENX ranking 0 / 6
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.